Medtronic (MDT) Financial Analysis & Valuation | Quarter Chart

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices... more
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems... more

Company facts

Reported company information and share structure.

Company Share structure
Market Cap$128.70BExchangeNYSE
SectorHealthcareIndustryMedical - Devices
CountryIECEOGeoffrey Straub Martha
IPO Date1973-05-02CAGR11.92%
Employees95,000Websitewww.medtronic.com
Div. Yield2.22%Payout Ratio70%
Buy Back Yield0.71%Total Yield2.93%
MDT chart loading...

Key metrics

Reported fundamentals and market-derived technical indicators.

Fundamentals Technicals
EV$116.34BP/E18.19Forward P/E15.71PEG0.61
P/S4.22P/B—P/CF20.35P/FCF26.57
Sales$37.54BSales 1Y9.77%Sales 3Y18.96%Sales 5Y18.82%
EPS$5.53EPS 1Y11.85%EPS 3Y49.82%EPS 5Y41.96%
Sales QoQ-0.52%EPS QoQ18.75%Sales QoQ Avg3.33%EPS QoQ Avg10.47%
Gross Margin66.69%Operating Margin18.08%Profit Margin13.93%ROCE631.26%
ROA411%ROE14%Altman Z Score—Piotroski Score9
Current Ratio8.93Quick Ratio10.14Cash Ratio9.01Op. CF Ratio9.01
Debt/Equity—Debt/Assets—Lt Debt/EquitynanLt Debt/Cap.—
Intrst Cov.9.36Inventory Turnover-52.1Asset Turnover29.47Receivables Turnover167.6
Enterprise Value$116.34BP/E Ratio18.19
Forward P/E15.71PEG Ratio0.61
P/S Ratio4.22P/B Ratio—
P/CF Ratio20.35P/FCF Ratio26.57
EPS$5.53EPS Growth 1Y11.85%
EPS Growth 3Y49.82%EPS Growth 5Y41.96%
Revenue Growth 1Y9.77%Gross Margin66.69%
Operating Margin18.08%Profit Margin13.93%
ROE14%ROA411%
ROCE631.26%Current Ratio8.93
Quick Ratio10.14Cash Ratio9.01
Debt/Equity—Interest Coverage9.36
Altman Z Score—Piotroski Score9